Pfizer (PFE) Drags on XLV ETF
Tweet
Share
E-mail
Health Care Select Sector SPDR Holdings (NYSE: XLV) was down early Tuesday after Pfizer (NYSE: PFE) reported Q1 earnings and offered a FY12 outlook.
Pfizer Inc makes up 11.76 percent of XLV ETF, its second largest holding behind Johnson & Johnson (NYSE: JNJ).
After trading to as low as $22.55 (down about 1.5 percent), Pfizer shares began grinding back to even as the broader stock market lifted the pharma giant. Stocks surged at 10am ET as data from the Institute of Supply Management came in better than expected. While Pfizer shares are now flat, the XLV ETF is up 0.5 percent.
Pfizer Inc makes up 11.76 percent of XLV ETF, its second largest holding behind Johnson & Johnson (NYSE: JNJ).
After trading to as low as $22.55 (down about 1.5 percent), Pfizer shares began grinding back to even as the broader stock market lifted the pharma giant. Stocks surged at 10am ET as data from the Institute of Supply Management came in better than expected. While Pfizer shares are now flat, the XLV ETF is up 0.5 percent.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FDA grants priority review for Pfizer's Talzenna and Xtandi combo in prostate cancer
- Goldman Sachs Starts Technoprobe SpA (TPRO:IM) at Buy
- NB Bancorp, Inc. (NBBK) Tops Q2 EPS by 14c
Create E-mail Alert Related Categories
ETFsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
